Early Access — free while we kick the tires
EdgarHawk

Ballal Rahul D.

Director

Director
1 filing analyzed · 1 company · Latest 2024-11-12

Companies

Company Buys Sells Direction
AGIOS PHARMACEUTICALS, INC. AGIO 0 7 Net selling

Activity

November 2024
medium
Sell
20,000 shares
$1,117,147
Significance 6/10

Ballal (Director) sold 20,000 shares of AGIO for $1,117,146.69 across 5 transactions; stock up 38.4% in 30 days.

Ballal Rahul D. executed 5 separate sales totaling 20,000 shares for $1,117,146.69 between 2024-11-07 and 2024-11-08, reducing his holdings from 28.0K to 8.0K shares (-71.4%). The sales occurred at prices ranging from $53.32 to $59.21, with a blended average of $55.86, near the current price of $59.02 and within 2.4% of the 52-week high of $60.46. Notably, AGIO stock has risen 38.4% over the prior 30 days and 32.1% over 90 days, suggesting the director's sales followed significant recent appreciation. The company's fundamentals show strong recent performance: annual revenue growth of +88.4%, a P/E of 4.99, and reported net income of $947.9M in the latest quarter, though full-year FY results showed negative net income. The director's historical cross-ticker sell track record shows a 75% well-timed rate with an average 90-day post-sale return of -1.8%, indicating past sales have generally been timed ahead of declines. This transaction's significance is moderated by the sector-wide context and valuation metrics, though the magnitude of the reduction and the timing relative to recent strong momentum warrant attention.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access